Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.39 |
| ▸ | TPMT | P51580 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | NQO2 | P16083 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17099695 | 0.86 | L3MBTL1 (0.42) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL17118264 | 0.76 | L3MBTL1 (0.39) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL17118255 | 0.74 | L3MBTL1 (0.37) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL26580392 | 0.73 | KDM4E (0.61) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL644451 | 0.71 | KMT2A (0.55) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL23809354 | 0.70 | ALDH1A1 (0.57) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL27938424 | 0.69 | KDM4E (1.00) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL2905589 | 0.69 | ALDH1A1 (0.60) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL26581211 | 0.68 | HPGD (0.51) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL19009885 | 0.66 | L3MBTL1 (0.36) | HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174825-A1 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY | 2017-06-22 | — | — | US | claimed |
| US-11370878-B2 | Systems and methods for production of artificial eumelanin | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) | 2022-06-28 | — | — | US | disclosed |
| US-20200407490-A1 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY | 2020-12-31 | — | — | US | disclosed |
| US-10774175-B2 | Systems and methods for production of artificial eumelanin | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) | 2020-09-15 | — | — | US | disclosed |
| US-20200031988-A1 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY | 2020-01-30 | — | — | US | disclosed |
| US-20170174825-A1 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY | 2017-06-22 | — | — | US | disclosed |
| WO-2015143020-A1 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN | THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) | 2015-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174825-A1 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN | TYR, COMT, VARS1 | HSD17B10 2925/4885ALDH1A1 3755/4885HPGD 1318/4885 |
| US-20200031988-A1 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN | TYR, COMT, VARS1 | HSD17B10 2925/4885ALDH1A1 3755/4885HPGD 1318/4885 |
| US-10774175-B2 | Systems and methods for production of artificial eumelanin | TYR, COMT, VARS1 | HSD17B10 2925/4885ALDH1A1 3755/4885HPGD 1318/4885 |
| US-11370878-B2 | Systems and methods for production of artificial eumelanin | TYR, COMT, VARS1 | HSD17B10 2925/4885ALDH1A1 3755/4885HPGD 1318/4885 |
| US-20200407490-A1 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN | TYR, COMT, VARS1 | HSD17B10 2925/4885ALDH1A1 3755/4885HPGD 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.